LPL Financial

LPL Financial’s Arcutis Biotherapeutics ARQT Stock Holding History

LPL Financial’s Portfolio ARQT Stock Details ARQT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.81M	Buy	119,381 +7,507	+7%	+$192K	﹤0.01%	3188
2025 Q4	$3.25M	Sell	111,874 -5,050	-4%	-$129K	﹤0.01%	2930
2025 Q3	$2.2M	Sell	116,924 -4,693	-4%	-$74K	﹤0.01%	3227
2025 Q2	$1.71M	Buy	121,617 +5,860	+5%	+$82.2K	﹤0.01%	3275
2025 Q1	$1.81M	Sell	115,757 -5,135	-4%	-$72.3K	﹤0.01%	3037
2024 Q4	$1.68M	Sell	120,892 -5,388	-4%	-$59K	﹤0.01%	3027
2024 Q3	$1.17M	Sell	126,280 -23,260	-16%	-$230K	﹤0.01%	3240
2024 Q2	$1.39M	Sell	149,540 -8,665	-5%	-$78.4K	﹤0.01%	2943
2024 Q1	$1.57M	Sell	158,205 -31,438	-17%	-$235K	﹤0.01%	2766
2023 Q4	$613K	Buy	189,643 +106,130	+127%	+$289K	﹤0.01%	3505
2023 Q3	$443K	Buy	83,513 +48,931	+141%	+$416K	﹤0.01%	3587
2023 Q2	$330K	Buy	+34,582	New	+$384K	﹤0.01%	3770

Other funds holding ARQT

Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return